Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL
Authors:
Open Access
- 20 July 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (33) , 53679-53701
Abstract
Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALLKeywords
This publication has 50 references indexed in Scilit:
- IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALLBlood, 2014
- Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemiaLeukemia, 2013
- Ikaros and Tumor Suppression in Acute Lymphoblastic LeukemiaCritical Reviews™ in Oncogenesis, 2011
- IKZF1(Ikaros) Deletions inBCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP ReportJournal of Clinical Oncology, 2009
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2009
- Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialBlood, 2006
- Treatment of Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2006
- Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer GroupLeukemia, 2004
- Recent approaches in acute lymphoblastic leukemia in adultsCritical Reviews in Oncology/Hematology, 2000